title: Effects of simvastatin alone versus fenofibrate alone versus simvastatin plus fenofibrate on lipoprotein subparticle profiles in patients with diabetes mellitus and mixed dyslipidemia.
authors.forename: Vasilios G
authors.initials: VG
authors.lastname: Athyros
authors.forename: Anna I
authors.initials: AI
authors.lastname: Kakafika
authors.forename: Asterios
authors.initials: A
authors.lastname: Karagiannis
authors.forename: Asterios
authors.initials: A
authors.lastname: Koragiannis
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: Dimitri P
authors.initials: DP
authors.lastname: Mikhalidis
mesh_terms: D003920:Diabetes Mellitus / Q000097:blood*; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D011345:Fenofibrate / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood*; D019821:Simvastatin / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008074:Lipoproteins; D019821:Simvastatin; D011345:Fenofibrate